Tai L Guo Selected Research

Tai L Guo Research Topics

Disease

9	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 04/2015
7	Inflammation (Inflammations) 11/2022 - 08/2014
6	Body Weight (Weight, Body) 02/2023 - 01/2009
5	Neoplasms (Cancer) 04/2021 - 12/2007
4	Hyperglycemia 01/2021 - 01/2016
3	Insulin Resistance 01/2021 - 05/2019
2	Carcinogenesis 01/2021 - 12/2007
2	Glucose Intolerance 01/2021 - 01/2019
2	Hypersensitivity (Allergy) 10/2020 - 07/2008
2	Respiratory Hypersensitivity 10/2020 - 09/2004
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 08/2014
2	Infections 04/2012 - 12/2005
2	Alzheimer Disease (Alzheimer's Disease) 02/2012 - 08/2010
1	Hypoxia (Hypoxemia) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Fatty Liver 02/2020
1	Prostatitis 01/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Dysbiosis 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Polydipsia 01/2016
1	Hyperphagia (Overeating) 01/2016
1	Hypertension (High Blood Pressure) 11/2014
1	Experimental Diabetes Mellitus 11/2014
1	Infarction (Infarctions) 11/2012
1	Myocardial Infarction 11/2012
1	Contact Dermatitis (Eczema, Contact) 10/2011
1	Neuroblastoma 08/2010
1	Hyperalgesia 07/2010
1	Pain (Aches) 07/2010
1	Edema (Dropsy) 07/2010

Drug/Important Bio-Agent (IBA)

8	GenisteinIBA 10/2020 - 12/2007
5	Phytoestrogens (Phytoestrogen)IBA 01/2020 - 07/2008
4	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 10/2017
4	CytokinesIBA 04/2019 - 09/2004
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2016
2	LigandsIBA 04/2021 - 02/2012
2	bis(4-hydroxyphenyl)sulfoneIBA 01/2021 - 06/2019
2	Whey ProteinsIBA 01/2020 - 05/2019
2	IsoflavonesIBA 01/2020 - 06/2019
2	Polychlorinated Dibenzodioxins (TCDD)IBA 04/2019 - 01/2016
2	InterleukinsIBA 04/2019 - 09/2004
2	ChemokinesIBA 01/2019 - 10/2017
2	bisphenol AIBA 01/2019 - 01/2019
2	Estrogens (Estrogen)FDA Link 08/2014 - 07/2008
2	CurcuminIBA 02/2012 - 08/2010
2	CholesterolIBA 02/2012 - 08/2010
2	Drinking WaterIBA 10/2011 - 01/2009
1	CelluloseIBA 02/2023
1	Immunoglobulin A (IgA)IBA 11/2022
1	LuciferasesIBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2021
1	Transcription Factors (Transcription Factor)IBA 04/2021
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 04/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Dietary Advanced Glycation End ProductsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 10/2020
1	Eosinophil PeroxidaseIBA 10/2020
1	AllergensIBA 10/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	daidzeinIBA 06/2019
1	Streptozocin (Streptozotocin)FDA Link 05/2019
1	AutoantigensIBA 05/2019
1	InterferonsIBA 04/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	Advanced Glycation End ProductsIBA 01/2019
1	Conditioned Culture MediaIBA 01/2018
1	AntibodiesIBA 10/2017
1	Caseins (Casein)FDA Link 10/2017
1	SodiumIBA 11/2014
1	SaltsIBA 11/2014
1	Serine Proteases (Serine Protease)IBA 08/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	AnisomycinIBA 11/2012
1	CPG-oligonucleotideIBA 04/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2012
1	bixinIBA 10/2011
1	norbixinIBA 10/2011
1	Membrane LipidsIBA 08/2010
1	Amyloid beta-PeptidesIBA 08/2010
1	AntioxidantsIBA 08/2010
1	CannabinoidsIBA 07/2010
1	LipopolysaccharidesIBA 07/2010
1	EndocannabinoidsIBA 07/2010
1	AcidsIBA 07/2010
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 07/2010
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 07/2010
1	anandamide (arachidonylethanolamide)IBA 07/2010
1	EstersIBA 07/2010

Therapy/Procedure

1	Immunomodulation 01/2021
1	Transplantation 11/2014
1	Therapeutics 11/2014
1	Oral Administration 01/2013
1	Analgesia 07/2010